You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 114 No. 7, July 1996 TABLE OF CONTENTS
  Archives
  •  Online Features
  CLINICAL SCIENCES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (37)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Measuring Visual Function and Quality of Life in Patients With Cytomegalovirus Retinitis

Development of a Questionnaire

Albert W. Wu, MD, MPH; Laura C. Coleson, RN, MPH; Janet Holbrook, MS, MPH; Douglas A. Jabs, MD; Studies of Ocular Complication of AIDS Research Group

Arch Ophthalmol. 1996;114(7):841-847.


Abstract

Objective
To develop and test a brief questionnaire designed to assess visual symptoms, visual function in daily activities, and impact of treatment administration in patients with cytomegalovirus retinitis related to acquired immunodeficiency syndrome.

Design
Observational cross-sectional study. Patients were recruited in June and July 1992.

Setting
Seven university-based sites participating in the Studies of Ocular Complications of AIDS.

Patients
Twenty-six subjects enrolled in a randomized trial that compared foscarnet and ganciclovir for the treatment of cytomegalovirus retinitis.

Main Outcome Measures and Analysis
Distributions of scores, reliability, and validity of newly developed scales to assess visual function, visual symptoms, and global vision. Spearman rank correlations with 95% confidence intervals were used to test hypothesized relationships between scale scores, visual acuity, visual field, and findings from visual examination.

Results
The final 18-item self-administered questionnaire required 5 minutes to complete. The new scales had high internal consistency (Cronbach {alpha}=.81 to.94). As hypothesized, patient-reported vision scores decreased with greater abnormalities found on ophthalmologic examination. Visual symptoms were most strongly related to findings in the worse eye. Visual function and global vision scores were moderately correlated with findings from visual testing and examination, and less strongly related to general health perceptions. Patients reported considerable impairment: 42% reported blurred vision; 40%, difficulty reading; 44%, difficulty driving; and 40%, that treatment interfered with social activities; 50% reported substantial trouble with their vision.

Conclusions
The brief questionnaire developed to assess patient-reported visual function in cytomegalovirus retinitis appears reliable and valid as a measure of performance of vision-related activities, visual symptoms, and the impact of treatment administration. Further research is needed to test its utility as an outcome measure in longitudinal studies of cytomegalovirus retinitis.



Author Affiliations

From the Departments of Health Policy and Management (Dr Wu) and Epidemiology (Ms Holbrook), School of Hygiene and Public Health, and the Departments of Medicine (Drs Wu and Jabs) and Ophthalmology (Ms Coleson and Dr Jabs), School of Medicine, The Johns Hopkins University, Baltimore, Md. Members of the Studies of Ocular Complication of AIDS Research Group are listed in a box on page 846.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Evaluation of the Relationship Between Ablation Diameter, Pupil Size, and Visual Function With Vision-Specific Quality-of-Life Measures After Laser In Situ Keratomileusis
Schmidt et al.
Arch Ophthalmol 2007;125:1037-1042.
ABSTRACT | FULL TEXT  

The VF-14 and Psychological Impact of Amblyopia and Strabismus.
Sabri et al.
IOVS 2006;47:4386-4392.
ABSTRACT | FULL TEXT  

The Development of the LV Prasad-Functional Vision Questionnaire: A Measure of Functional Vision Performance of Visually Impaired Children
Gothwal et al.
IOVS 2003;44:4131-4139.
ABSTRACT | FULL TEXT  

Correlation between visual function and visual ability in patients with uveitis
Gardiner et al.
Br J Ophthalmol 2002;86:993-996.
ABSTRACT | FULL TEXT  

Visual Function and Subjective Quality of Life Compared in Subjects with Acquired Macular Disease
Hazel et al.
IOVS 2000;41:1309-1315.
ABSTRACT | FULL TEXT  

Macular degeneration: do conventional measurements of impaired visual function equate with visual disability?
McClure et al.
Br J Ophthalmol 2000;84:244-250.
ABSTRACT | FULL TEXT  

A vision specific functional index for use in patients with age related macular degeneration
Hart et al.
Br J Ophthalmol 1999;83:1115-1120.
ABSTRACT | FULL TEXT  

Development of a disease specific quality of life questionnaire for patients with Graves' ophthalmopathy: the GO-QOL
Terwee et al.
Br J Ophthalmol 1998;82:773-779.
ABSTRACT | FULL TEXT  

MSL-109 Adjuvant Therapy for Cytomegalovirus Retinitis in Patients With Acquired Immunodeficiency Syndrome: The Monoclonal Antibody Cytomegalovirus Retinitis Trial
The Studies of Ocular Complications of AIDS Resear
Arch Ophthalmol 1997;115:1528-1536.
ABSTRACT  

Unperceived Visual Field Defects
Safran
Arch Ophthalmol 1997;115:686-687.
ABSTRACT  

Use of Quality-of-Life Instruments in Randomized Clinical Trials
Sommer
Arch Ophthalmol 1997;115:564-565.
ABSTRACT  

Acquired Immunodeficiency Syndrome and the Eye--1996
Jabs
Arch Ophthalmol 1996;114:863-866.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1996 American Medical Association. All Rights Reserved.